10-27504419-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_021252.5(RAB18):āc.50G>Cā(p.Ser17Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000212 in 1,416,972 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 32)
Exomes š: 0.0000021 ( 0 hom. )
Consequence
RAB18
NM_021252.5 missense
NM_021252.5 missense
Scores
2
12
5
Clinical Significance
Conservation
PhyloP100: 4.20
Genes affected
RAB18 (HGNC:14244): (RAB18, member RAS oncogene family) The protein encoded by this gene is a member of a family of Ras-related small GTPases that regulate membrane trafficking in organelles and transport vesicles. Knockdown studies is zebrafish suggest that this protein may have a role in eye and brain development. Mutations in this gene are associated with Warburg micro syndrome type 3. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAB18 | NM_021252.5 | c.50G>C | p.Ser17Thr | missense_variant | 1/7 | ENST00000356940.11 | NP_067075.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAB18 | ENST00000356940.11 | c.50G>C | p.Ser17Thr | missense_variant | 1/7 | 1 | NM_021252.5 | ENSP00000349415.7 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.0000112 AC: 2AN: 178594Hom.: 0 AF XY: 0.0000212 AC XY: 2AN XY: 94430
GnomAD3 exomes
AF:
AC:
2
AN:
178594
Hom.:
AF XY:
AC XY:
2
AN XY:
94430
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000212 AC: 3AN: 1416972Hom.: 0 Cov.: 31 AF XY: 0.00000143 AC XY: 1AN XY: 700052
GnomAD4 exome
AF:
AC:
3
AN:
1416972
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
700052
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 26, 2024 | The c.50G>C (p.S17T) alteration is located in exon 1 (coding exon 1) of the RAB18 gene. This alteration results from a G to C substitution at nucleotide position 50, causing the serine (S) at amino acid position 17 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;.;D;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;.;L;.;L
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;.;N;N;.
REVEL
Uncertain
Sift
Benign
T;.;D;D;.
Sift4G
Uncertain
D;T;T;T;T
Polyphen
0.83
.;.;P;.;.
Vest4
MutPred
Loss of glycosylation at S17 (P = 0.0676);Loss of glycosylation at S17 (P = 0.0676);Loss of glycosylation at S17 (P = 0.0676);Loss of glycosylation at S17 (P = 0.0676);Loss of glycosylation at S17 (P = 0.0676);
MVP
MPC
0.47
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at